TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
DNA Development i Stockholm AB
Closing information (x1000 SEK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
1,025
|
1,239
|
1,735 |
| Financial expenses |
0
|
4
|
117 |
| Earnings before taxes |
-105
|
-14
|
280 |
| EBITDA |
-116
|
-27
|
279 |
| Total assets |
1,588
|
2,041
|
2,548 |
| Current assets |
588
|
1,041
|
1,548 |
| Current liabilities |
38
|
102
|
244 |
| Equity capital |
1,461
|
1,833
|
2,198 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
92.0%
|
89.8%
|
86.3% |
| Turnover per employee |
1,025
|
1,239
|
1,735 |
| Profit as a percentage of turnover |
-10.2%
|
-1.1%
|
16.1% |
| Return on assets (ROA) |
-6.6%
|
-0.5%
|
15.6% |
| Current ratio |
1547.4%
|
1020.6%
|
634.4% |
| Return on equity (ROE) |
-7.2%
|
-0.8%
|
12.7% |
| Change turnover |
-214
|
-496
|
-787 |
| Change turnover % |
-17%
|
-29%
|
-31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.